5S-20S.
337. Harlander-Locke M, Lawrence PF, Alktaiﬁ A, Jimenez JC,
Rigberg D, DeRubertis B. The impact of ablation of incompetent
superﬁcial and perforator veins on ulcer healing rates. J Vasc Surg
2012;55:458-64.
338. Viarengo LMA, Poterio-Filho J, Poterio GMB, Menezes FH,
Meirelles GV. Endovenous laser treatment for varicose veins in
patients with active ulcers: Measurement of intravenous and perivenous temperatures during the procedure. Dermatol Surg 2007;33:
1234-41.
339. Gloviczki P, Bergan JJ, Menawat SS, Hobson RW 2nd, Kistner RL,
Lawrence PF, et al. Safety, feasibility, and early efﬁcacy of subfascial
endoscopic perforator surgery: A preliminary report from the North
American registry. J Vasc Surg 1997;25:94-105.
340. Tenbrook JA Jr, Iafrati MD, O’Donnell TF Jr, Wolf MP,
Hoffman SN, Pauker SG, et al. Systematic review of outcomes after
surgical management of venous disease incorporating subfascial
endoscopic perforator surgery. J Vasc Surg 2004;39:583-93.
341. Masuda FM, Kessler DM, Lurie F, Puggioni A, Kistner RL, Eklof B.
The effect of ultrasound-guided sclerotherapy of incompetent perforating veins on venous clinical severity and disability scores. J Vasc
Surg 2006;43:551-7.
342. Kinanifard B, Holdstock J, Allen C, Smith C, Price B, Whiteley MS.
Randomized clinical trial of the effect of adding subfascial endoscopic
perforator surgery to standard great saphenous vein stripping. Br J
Surg 2007;94:1075-80.
34